Human herpesvirus-8 seropositivity and clinical correlations in HIV-1-positive and highly exposed, persistently HIV-seronegative individuals in Greece

AIDS Patient Care and STDs

Volumn 19, Issue 6, 2005, Pages 375-383

  Panayiotakopoulos, George D ^a,d   Mavroyianni, Despina ^a   Politou, Marianna ^a   Aroni, Kyriaki ^a   Kosmopoulou, Olga ^a   Kontos, Athanasios N ^a   Choremi Papadopoulou, Helen ^b   Pediaditis, John ^c   Kordossis, Theodore ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

^c V and Pananion Gen Hosp Heraklion   (Greece)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CANCER RISK; CARCINOGENESIS; COHORT ANALYSIS; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GREECE; HERPES VIRUS INFECTION; HODGKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; NONHUMAN; PLASMACYTOMA; PROGNOSIS; RETROSPECTIVE STUDY; SERODIAGNOSIS; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CARCINOMA IN SITU;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; COHORT STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; FEMALE; GREECE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; PROBABILITY; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOMA, KAPOSI; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 21844479806     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2005.19.375     Document Type: Article

References (41)

1. Hengge UR, Ruzicka T, Tyring SK, et al. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: Epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2002;2:281-292.
2. Hengge UR, Ruzicka T, Tyring SK, et al. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: Pathogenesis, Castleman's disease, and pleural effusion lymphoma. Lancet Infect Dis 2002;2:344-352.
3. Schulz TF. KSHV (HHV8) infection. J Infect 2000;41: 125-129.
4. Schulz TF. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): Epidemiology and pathogenesis. J Antimicr Chem 2000;45(Suppl T3):15-27.
5. Andreoni M, Sarmati L, Nicastri E, et al. Primary human herpasvirus 8 infection in immunocompetent children. JAMA 2002;287:1295-1300.
6. Angeloni A, Heston L, Uccini S, et al. High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia. J Infect Dis 1998;177:1715-1718.
7. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996;2: 918-924.
8. Osmond DH, Buchbinder S, Cheng A, et al. Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV Epidemic JAMA 2002;287:221-225.
9. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996;2:925-928.
10. Renwick N, Halaby T, Weverling GJ, et al. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS 1998;12:2481-2488.
11. Marcelin AG, Dupin N, Bossi P, Descamps D, Simon F, Calvez V. Seroprevalence of human herpesvirus 8 in healthy subjects and patients with AIDS-associated and classical Kaposi's sarcoma in France. AIDS 1998;12:539-540.
12. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996;348:1133-1138.
13. Ablashi D, Chatlynne L, Cooper H, et al. Seroprevalence of human herpesvirus-8 (HHV8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer 1999;81:893-897.
14. Fujii T, Taguchi H, Katano H, et al. Seroprevalence of human herpesvirus 8 in human immunodeficiency virus 1-positive and human immunodeficiency virus1-negative populations in Japan. J Med Virol 1999;57:159-162.
15. Biggar RJ, Whitby D, Marshall V, Linhares AC, Black F. Human herpesvirus 8 in Brazilian Amerindians: A hyperendemic population with a new subtype. J Infect Dis 2000;181:1562-1568.
16. Dilnur P, Katano H, Wang ZH, et al. Classic type of Kaposi's sarcoma and human herpesvirus 8 infection in Xinjiang, China. Pathol Int 2001;51:845-852.
17. Calabro ML, Sheldon J, Favero A, et al. Seroprevalence of Kaposi's sarcoma associated herpesvirus 8 in several regions of Italy. J Hum Virol 1998;1:207-213.
18. Perna AM, Bonura F, Vitale F, et al. Antibodies to human herpesvirus type 8 (HHV8) in general population and in individuals at risk for sexually transmitted diseases in Western Sicily. Int J Epidemiol 2000;29: 175-179.
19. Serraino D, Toma L, Andreoni M, et al. A seroprevalence study of human herpesvirus type 8 (HHV8) in Eastern and Central Africa and in the Mediterranean area. Eur J Epidemiol 2001;17:871-876.
20. Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 1998;90:395-397.
21. Bestetti G, Renon G, Mauclere P, et al. High seroprevalence of human herpesvirus-8 in pregnant women and prostitutes from Cameroon. AIDS 1998; 12:541-543.
22. Mayama S, Cuevas LE, Sheldon J, et al. Prevalence and transmission of Kaposi's sarcoma associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 1998;77:817-820.
23. Schatz O, Monini P, Bugarini R, et al. Kaposi sarcoma-associated herpesvirus serology in Europe and Uganda: Multicentre study with multiple and novel assays. J Med Virol 2001;65:123-132.
24. EpiData [computer program]. Version 2.x. An extended tool for validated entry and documentation of data. Odense, Denmark: The EpiData Association, 2001-2003.
25. Epi Info [computer program]. Version 6. Atlanta: Centers for Disease Control and Prevention, 1995
26. Dallal GE. LOGISTIC: A Logistic Regression Program for the IBM PC. Am Statistician 1988;42:272.
27. Hosmer DW, Jr, and Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons, Inc, 1989.
28. Kleinbaum DG. Logistic Regression: A Self-Learning Text. New York: Springer-Verlag, Inc., 1994.
29. Gnann JW Jr, Pellett PE, Jaffe HW. Human herpesvirus 8 and Kaposi's sarcoma in persons infected with human immunodeficiency virus. Clin Infect Dis 2000;30:S72-76.
30. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996;348: 858-866.
31. Rezza G, Dorrucci M, Serraino D, et al. Incidence of Kaposi's sarcoma and HIV-8 seroprevalence among homosexual men with known dates of HIV seroconversion. Italian Seroconversion Study. AIDS 2000;28: 14:1647-1653.
32. Touloumi G, Kaklamanis L, Potouridou I, et al. The epidemiologic profile of Kaposi's sarcoma in Greece prior to and during the AIDS era. Int J Cancer 1997;70:538-541.
33. Cottoni F, De Marco R, Montesu MA. Classical Kaposi's sarcoma in northeast Sardinia: An overview from 1977 to 1991. Br J Cancer 1996;1132-1133.
34. Greenblatt RM, Jacobson LP, Levine AM, et al. Human Herpesvirus 8 infection and Kaposi's sarcoma among human immunodeficiency virus-infected and -uninfected women. J Infect Dis 2001;183:1130-1134.
35. Parisi SG, Sarmati L, Pappagallo M, et al. Prevalence trend and correlates of HHV-8 infection in HIV-infected patients. J Acquir Immune Defic Syndr 2002;29: 295-299.
36. Ablashi DV, Chatlynne LG, Whitman JE Jr, Cesarman E. Spectrum of Kaposi's sarcoma-associated herpesvirus or human herpesvirus 8, diseases. Clin Microbiol Rev 2002;15:439-464.
37. Quinlivan EB, Wang RX, Stewart PW, et al. Swiss HIV Cohort Study. Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS. J Med Virol 2001;64:157-166.
38. Rettig MB, Ma HJ, Vescio RA, et al. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 1997;276:1851-1854.
39. McDonagh DP, Liu J, Gaffey MJ, Layfield LJ, Azumi N, Traweek ST. Detection of Kaposi's sarcoma-associated herpesvirus-like DNA sequences in angiosarcoma. Am J Pathol 1996;49:1363-1368.
40. Inagi R, Kosuge H, Nishimoto S, Yoshikawa K, Yamanishi K. Kaposi's sarcoma-associated herpesvirus (KSHV) sequences in premalignant and malignant skin tumours. Arch Virol 1996;141:2217-2223.
41. Dukers NH, Renwick N, Prins M, et al. Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. Am J Epidemiol 2000;151:213-224.